Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
基本信息
- 批准号:8345107
- 负责人:
- 金额:$ 28.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAffectAnimalsAntigen ReceptorsB-Cell DevelopmentB-LymphocytesBenignBiological AssayCell LineCell LineageCell physiologyChromosomal RearrangementCleaved cellCodeComplexComplicationCullin ProteinsDNADNA RepairDNA Repair PathwayDNA Sequence AnalysisDNA Sequence RearrangementDNA biosynthesisDataDefectDevelopmentDiseaseDistalEpigenetic ProcessEventExhibitsFamilyFoundationsFrequenciesFunctional RNAG22P1 geneGene RearrangementGenesGenetic RecombinationGenetic TranscriptionGerm LinesHealthHistonesHumanImmuneImmune systemImmunityImmunodeficiency and CancerImmunologic Deficiency SyndromesKnowledgeLeadLengthLightLymphocyteMalignant NeoplasmsMalignant lymphoid neoplasmMature B-LymphocyteMeasuresMediatingModificationMolecular ProfilingMusMutationNonhomologous DNA End JoiningPathway interactionsPeptide Signal SequencesPhasePhosphotransferasesPopulation HeterogeneityProcessProtein BindingProteinsReceptor GeneRecurrenceRelative (related person)ResearchResolutionReverse Transcriptase Polymerase Chain ReactionRoleServicesSevere Combined ImmunodeficiencySouthern BlottingStagingSterilitySurface AntigensSyndromeT-Cell ReceptorT-LymphocyteTestingUbiquitinUrsidae FamilyV(D)J RecombinationVDJ RecombinasesViralWorkXRCC5 genebasechromatin immunoprecipitationhistone modificationimprovedleukemia/lymphomamicroorganismpreventreceptorrepairedubiquitin ligaseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): B and T lymphocytes form the foundation of our adaptive immune system, which is based on specific recognition of foreign molecules by structurally diverse surface antigen receptors. Structural diversity in these receptors originates from a somatic DNA rearrangement process, called V(D)J recombination, that assembles the antigen receptor genes during lymphocyte development. This process proceeds in two phases: a "cleavage phase" during which the RAG1 and RAG2 proteins bind and cleave a pair of receptor gene coding segments at specific recombination signal sequences, and a "joining phase" during which the four DNA ends resulting from RAG-mediated cleavage are reorganized, processed and rejoined via the non-homologous end- joining (NHEJ) repair pathway. Emerging evidence suggests that the introduction, sensing, and repair of DNA breaks is actively coordinated through RAG protein interactions with other factors, but the mechanisms involved in these processes are not fully understood. We have identified two NHEJ repair factors, Ku70 and Ku80, and components of an E3 ubiquitin ligase complex as interaction partners with full-length RAG1. These findings lead us to speculate that the cleavage and joining phases of V(D)J recombination are connected and regulated by a ubiquitin modification pathway. In support of this possibility, we show that one of the E3 ubiquitin ligase components, called VprBP, is required for B cell development past the pro-B cell stage in mice. This developmental block is partially rescued by enforced Bcl2 expression, but under these conditions most emerging mature B cells express the Ig¿ light chain. These data lead us to the specific hypothesis of this proposal: that VprBP is necessary for efficient and high-fidelity rearrangement of the large Igh and Igk loci, but not the more compact Igl locus. To test this hypothesis, we will establish the frequency and fidelity V(D)J recombination intermediates and products at the Igh, Igk, and Igl loci, as well as the accessibility of these loci, in VprBP-deficient B cells in the absence or presence of enforced Bcl2 expression. In addition, we will determine which step(s) of V(D)J recombination are specifically disrupted by loss of VprBP function using viral Abelson-transformed pre-B cell lines. Greater knowledge of how factors interacting with the RAG proteins, such as VprBP, guide the introduction, sensing, and repair of DNA breaks will improve our understanding of the mechanisms contributing to impaired and aberrant V(D)J recombination that underlie certain forms of immunodeficiency and lymphoid malignancy, respectively.
PUBLIC HEALTH RELEVANCE: V(D)J recombination is a DNA rearrangement process that is responsible for generating a diverse population of B and T cells that together provide highly specific immunity to pathogenic microorganisms. V(D)J recombination is both essential and potentially dangerous to the host: defects in V(D)J recombination account for about 30% of human cases of severe combined immunodeficiency, yet certain forms of leukemia and lymphoma frequently bear molecular signatures implicating an aberrant V(D)J recombination event in their genesis. The research proposed here will investigate how VprBP, a component of an ubiquitin ligase complex that we have found associates with V(D)J recombinase, regulates V(D)J recombination during B cell development, which will improve our understanding of how this process contributes to B cell immune diversification and disease.
描述(由申请人提供):B 和 T 淋巴细胞构成了我们的适应性免疫系统的基础,该系统基于结构多样的表面抗原受体对外来分子的特异性识别。这些受体的结构多样性源于体细胞 DNA 重排过程,称为 V(D)J 重组,该过程在淋巴细胞发育过程中组装抗原受体基因。该过程分两个阶段进行:“切割阶段”,在此期间,RAG1 和 RAG2 蛋白在特定的重组信号序列处结合并切割一对受体基因编码片段;以及“连接阶段”,在此期间,由 RAG 介导的切割产生的四个 DNA 末端通过非同源末端连接 (NHEJ) 修复途径进行重组、加工和重新连接。新出现的证据表明,DNA 断裂的引入、感知和修复是通过 RAG 蛋白与其他因子的相互作用来积极协调的,但这些过程中涉及的机制尚未完全了解。我们已经确定了两个 NHEJ 修复因子 Ku70 和 Ku80 以及 E3 泛素连接酶复合物的成分作为与全长 RAG1 的相互作用伙伴。这些发现使我们推测 V(D)J 重组的裂解和连接阶段是由泛素修饰途径连接和调节的。为了支持这种可能性,我们证明了 E3 泛素连接酶成分之一(称为 VprBP)是小鼠 B 细胞发育经过前 B 细胞阶段所必需的。这种发育障碍可以通过强制 Bcl2 表达得到部分挽救,但在这种情况下,大多数新兴的成熟 B 细胞都表达 Ig¿ 轻链。这些数据引导我们得出该提议的具体假设:VprBP 对于大 Igh 和 Igk 基因座的高效和高保真重排是必需的,但对于更紧凑的 Igl 基因座则不是必需的。为了检验这一假设,我们将在缺乏或存在强制 Bcl2 表达的 VprBP 缺陷 B 细胞中确定 Igh、Igk 和 Igl 位点处 V(D)J 重组中间体和产物的频率和保真度,以及这些位点的可及性。此外,我们将使用病毒 Abelson 转化的前 B 细胞系来确定 V(D)J 重组的哪些步骤因 VprBP 功能的丧失而被特异性破坏。更多地了解与 RAG 蛋白相互作用的因子(例如 VprBP)如何指导 DNA 断裂的引入、感知和修复,将提高我们对导致某些形式的免疫缺陷和淋巴恶性肿瘤的受损和异常 V(D)J 重组的机制的理解。
公共卫生相关性:V(D)J 重组是一种 DNA 重排过程,负责产生多样化的 B 细胞和 T 细胞群体,这些细胞共同提供针对病原微生物的高度特异性免疫力。 V(D)J 重组对宿主来说既重要又具有潜在危险:V(D)J 重组缺陷约占人类严重联合免疫缺陷病例的 30%,但某些形式的白血病和淋巴瘤经常带有暗示其发生过程中存在异常 V(D)J 重组事件的分子特征。这里提出的研究将调查 VprBP(我们发现与 V(D)J 重组酶相关的泛素连接酶复合物的一个组成部分)如何在 B 细胞发育过程中调节 V(D)J 重组,这将提高我们对这一过程如何促进 B 细胞免疫多样化和疾病的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick C. Swanson其他文献
Receptor editing constrains development of phosphatidyl choline-specific B cells in VsubH/sub12-transgenic mice
- DOI:
10.1016/j.celrep.2022.110899 - 发表时间:
2022-06-14 - 期刊:
- 影响因子:6.900
- 作者:
Alexandra N. Worth;Victoria L. Palmer;N. Max Schabla;Greg A. Perry;Anna N. Fraser-Philbin;Patrick C. Swanson - 通讯作者:
Patrick C. Swanson
Patrick C. Swanson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick C. Swanson', 18)}}的其他基金
Role of RACK1 in RAG1 degradation and B cell development
RACK1 在 RAG1 降解和 B 细胞发育中的作用
- 批准号:
10430247 - 财政年份:2021
- 资助金额:
$ 28.74万 - 项目类别:
Role of RACK1 in RAG1 degradation and B cell development
RACK1 在 RAG1 降解和 B 细胞发育中的作用
- 批准号:
10302865 - 财政年份:2021
- 资助金额:
$ 28.74万 - 项目类别:
DCAF1(VprBP) regulates FoxO1 to promote Rag transcription
DCAF1(VprBP)调控FoxO1促进Rag转录
- 批准号:
9808408 - 财政年份:2019
- 资助金额:
$ 28.74万 - 项目类别:
Implications of B10-like cell expansion in a model of impaired receptor editing
B10 样细胞扩增对受体编辑受损模型的影响
- 批准号:
9244625 - 财政年份:2016
- 资助金额:
$ 28.74万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8876720 - 财政年份:2012
- 资助金额:
$ 28.74万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8499380 - 财政年份:2012
- 资助金额:
$ 28.74万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8688270 - 财政年份:2012
- 资助金额:
$ 28.74万 - 项目类别:
Defining the role of a novel E3 ubiquitin ligase in V(D)J recombination
定义新型 E3 泛素连接酶在 V(D)J 重组中的作用
- 批准号:
8313160 - 财政年份:2011
- 资助金额:
$ 28.74万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 28.74万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 28.74万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 28.74万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 28.74万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 28.74万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 28.74万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 28.74万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 28.74万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 28.74万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 28.74万 - 项目类别:
Research Grant